Ten years ago, scientists put DNA barcodes in AAV vectors, creating an approach that simplified, expedited, and streamlined AAV screening. 

As nonconventional medical treatments become increasingly mainstream, we take a look at the science behind some of the most popular.

Scientists have genetically modified isolated microbes for decades. Now, using CRISPR, they intend to target entire microbiomes.

In trouble? The sea otter is dying from parasitic diseases for which the only known hosts are terrestrial mammals.

Meritxell Huch tackled her pipedream of growing three-dimensional pancreatic tissue in a dish.

A key mutation turns healing cells into cancer promoters.

Sometime in the 1980s, the emerging infectious disease (EID) movement began. The "emerging" label had been used earlier, but a series of high-profile disease outbreaks in the 1980s, combined with perceived funding gaps, began to galvanize the field. A book by Richard Krause of the National Institutes of Health1 formed part of the initial thrust. Published in the same year as the recognition of AIDS, it commented on the alarming phenomenon of antibiotic-resistant microbes. Further threats surfac

To understand how memories are formed and maintained, neuroscientists travel far beyond the cell body in search of answers.

Damaged lysosomes are repaired by a lipid-based signaling pathway dubbed PITT that could be targeted to treat neurodegenerative disease, its discoverers say.

Emerging infections provide clues about how pathogens might evolve when farm animals are protected from infection.